Bristol Myers partners with Microsoft for AI-driven lung cancer detection

The collaboration will deploy U.S. Food and Drug Administration-cleared radiology AI algorithms through Microsoft’s Precision Imaging Network, which analyzes X-ray and CT images to help identify lung disease and is used by hospitals in the United States, the companies said.

Sign up here.

Bristol Myers said the tools could help clinicians spot hard-to-detect lung nodules and identify some patients at earlier stages of disease.

The drugmaker said a key aim of the partnership is to expand access to early detection in medically underserved communities, including rural hospitals and community clinics across the United States.

“By combining Microsoft’s highly scalable radiology solutions with Bristol’s deep expertise in oncology and drug…